Juan Olivero
Nephrology · Houston, TXNPI 1295783991
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by AstraZeneca at 37.5% of the total. That places this record below the midpoint for nephrology clinicians in TX, where the typical reported total is $1,420.
Across 22 payments — averaging $16.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$134
- Amgen$124
- Fresenius USA Marketing, Inc.$44
- Vifor Pharma, Inc.$39
- Ultragenyx Pharmaceutical Inc.$16
Across 64 payments — averaging $7040.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$342K
- Akebia Therapeutics Inc$83K
- AstraZeneca$21K
- Astrazeneca UK Limited$6K
What the payments were for
- Food & beverage$357100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 9 | $134 |
| Amgen | 7 | $124 |
| Fresenius USA Marketing, Inc. | 2 | $44 |
| Vifor Pharma, Inc. | 3 | $39 |
| Ultragenyx Pharmaceutical Inc. | 1 | $16 |
How this compares
$357 in reported general payments places this provider in the 20th percentile of 1,070 nephrology providers in Texas.
Other nephrology in Houston
- Sreedhar MandayamHouston$752K
- Christopher KwohHouston$467K
- Wolfgang WinkelmayerHouston$462K
- Namrata GoelHouston$426K
- Dana MitchellHouston$344K
- Ramachandra MalyaHouston$312K
- John ForingerHouston$215K
- Biruh WorkenehHouston$185K
- Horacio AdrogueHouston$122K
- Anand SaranathanHouston$109K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.